Sts, you are late as usual, no punch, hikma stock increase is fake news. No change for them, meaning this is nothing burger for them or street does not think the market is ripe.
Hikma trades on the London exchange. Is a multi billion dollar company and the price did not move,
HKMPF is either some unrelated stock or a US tracker that means nothing. It traded 325 shares on the morning news at $129, but the bid is still at $33. Most likely somebody screwed up, or possible was game playing hoping to get follow on buying at whatever that symbol really is.
Look what we witnessed was a travesty which we need to get over but not forget. Vascepa is still the most valuable drug. The only location where generics can compete is the US a country with a population of approx 380 million in a world with a population of 7.8 billion. So this travesty covers approx 4% of the worlds population. Amarin should now create a second entity for the US to flood generic land with the cheapest shit version of EPA possible destroy the market for the generics. Amarin (rest of world) then forge ahead with real Vascepa, available to everyone on the planet including US citizens prepared to pay for quality. This part of Amarin is worth a fortune in a buyout.
Market Data 
Markets 
